Waltham's Morphic Therapeutic inks $100M deal with AbbVie
October 18, 2018 at 08:24 AM EDT
A preclinical Waltham biotech company is hoping to launch their first clinical trial of a fibrosis treatment next year after signing a $100 million collaboration agreement with AbbVie this week.
